Cowen Prime Advisors’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Cowen Prime Advisors’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-8,000	Closed	-$193K	–	325
2014 Q2	$193K	Buy	+8,000	New	+$83.4K	0.08%	101

Cowen Prime Advisors's IDIX Position: Q3 2014 in Review

Cowen Prime Advisors sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 8,000 shares — an estimated $193K sold.

Cowen Prime Advisors first reported a position in IDIX in Q2 2014 and held it in 1 quarter. The position peaked at $193K in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

Cowen Prime Advisors reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
Cowen Prime Advisors sold 8,000 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $193K.
Cowen Prime Advisors first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2014 and held it in 1 quarter.
Cowen Prime Advisors's IDENIX PHARMACEUTICALS INC position peaked at $193K in Q2 2014.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Cowen Prime Advisors's 13F filing for Q3 2014, filed 12 Nov 2014.